A detailed history of Renasant Bank transactions in Haleon PLC stock. As of the latest transaction made, Renasant Bank holds 12,155 shares of HLN stock, worth $102,952. This represents 0.07% of its overall portfolio holdings.

Number of Shares
12,155
Previous 10,109 20.24%
Holding current value
$102,952
Previous $83,000 24.1%
% of portfolio
0.07%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$8.02 - $8.67 $16,408 - $17,738
2,046 Added 20.24%
12,155 $103,000
Q4 2023

Feb 12, 2024

SELL
$7.78 - $8.62 $147 - $163
-19 Reduced 0.19%
10,109 $83,000
Q3 2023

Nov 01, 2023

BUY
$7.85 - $8.94 $79,504 - $90,544
10,128 New
10,128 $84,000
Q1 2023

May 05, 2023

BUY
$7.57 - $8.37 $83,315 - $92,120
11,006 New
11,006 $89,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $39.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Renasant Bank Portfolio

Follow Renasant Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

News

Stay updated on Renasant Bank with notifications on news.